Jiangsu East-Mab Biomedical Technology Co., Ltd., a leading national high-tech enterprise in China, is proud to announce the successful development and market launch of its latest product, Y00331 Recombinant Bovine bFGF/FGF-2. This breakthrough product is designed to meet the growing demand for high-quality recombinant proteins in the biomedical and industrial sectors.
Y00331 Recombinant Bovine bFGF/FGF-2, also known as basic Fibroblast Growth Factor, is a critical component widely used in cell culture, tissue engineering, and regenerative medicine. It plays a pivotal role in promoting cell growth, proliferation, and differentiation, making it essential in stem cell research, wound healing, and drug development. This product offers unparalleled performance and reliability, ensuring consistency and efficiency for researchers and pharmaceutical companies.

Key Features and Applications:
High Purity and Stability: Y00331 is produced under stringent quality control standards to ensure its purity and stability, providing reproducible results for applications in biomedical research and industrial-scale production.
Enhanced Bioactivity: The recombinant bFGF/FGF-2 is engineered to retain its full biological activity, ensuring effective stimulation of cell growth and regeneration, vital in areas such as tissue repair and regenerative therapies.
Wide Range of Applications: This product is suitable for a variety of applications, including stem cell culture, tissue scaffolding, drug discovery, and IVD (in vitro diagnostics). Its versatility makes it an ideal choice for industries and research institutions looking for reliable, high-performance growth factors.

Commitment to Innovation and Quality: East-Mab Bio is committed to advancing the biopharmaceutical industry by developing innovative solutions that address the needs of modern healthcare and research. The launch of Y00331 marks another milestone in the company's mission to provide cutting-edge products that meet global standards of quality and performance.
"With the successful launch of Y00331 Recombinant Bovine bFGF/FGF-2, we are excited to offer a new solution that aligns with the increasing demands for high-quality recombinant proteins in both the biomedical and industrial fields," said [Executive Name], CEO of Jiangsu East-Mab Biomedical Technology. "This product underscores our commitment to driving biotechnological innovation and delivering value to our partners worldwide."

About Jiangsu East-Mab Biomedical Technology Co., Ltd.: Founded in 2016, Jiangsu East-Mab Bio is a national high-tech enterprise specializing in the research, development, and production of recombinant proteins and biopharmaceutical raw materials. With a state-of-the-art production facility in Nantong, China, and a product application development platform in Suzhou, the company is equipped to provide high-quality, industrial-grade materials to support the global biopharmaceutical industry. The company has achieved multiple ISO certifications and adheres to strict international standards in product development and quality control.